A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis-Reference-Cited by-同舟云学术

A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis

Published:2021-08 Issue:2 Volume:162 Page:292-298
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ishikawa Mitsuya,Shibata Taro,Iwata Takashi,Nishio Shin,Takada Toshio,Suzuki Shiro,Horie Koji,Kudaka Wataru,Kagabu Masahiro,Tanikawa Michihiro,Kitagawa Ryo,Takekuma Munetaka,Kobayashi Hiroaki,Yaegashi Nobuo

Funder

National Cancer Center

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study;Bonomi;J. Clin. Oncol.,1985

2. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study;Omura;J. Clin. Oncol.,1997

3. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study;Moore;J. Clin. Oncol.,2004

4. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study;Long;J. Clin. Oncol.,2005

5. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study;Monk;J. Clin. Oncol.,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects;Cancer Investigation;2024-07-05

2. Chemotherapy for Advanced and Recurrent Cervical Cancer;Comprehensive Gynecology and Obstetrics;2024

3. Heterogeneity of vulnerability and taste changes in older cancer patients undergoing chemotherapy: a latent class analysis;Supportive Care in Cancer;2023-06-13

4. Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311);International Journal of Gynecologic Cancer;2023-03-30

5. Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2023-03-04